Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The SEURAT-1 approach towards animal free human safety assessment.
Gocht T, Berggren E, Ahr HJ, Cotgreave I, Cronin MT, Daston G, Hardy B, Heinzle E, Hescheler J, Knight DJ, Mahony C, Peschanski M, Schwarz M, Thomas RS, Verfaillie C, White A, Whelan M. Gocht T, et al. Among authors: peschanski m. ALTEX. 2015;32(1):9-24. doi: 10.14573/altex.1408041. Epub 2014 Nov 5. ALTEX. 2015. PMID: 25372315 Free article.
Biological abnormalities of peripheral A(2A) receptors in a large representation of polyglutamine disorders and Huntington's disease stages.
Varani K, Bachoud-Lévi AC, Mariotti C, Tarditi A, Abbracchio MP, Gasperi V, Borea PA, Dolbeau G, Gellera C, Solari A, Rosser A, Naji J, Handley O, Maccarrone M, Peschanski M, DiDonato S, Cattaneo E. Varani K, et al. Among authors: peschanski m. Neurobiol Dis. 2007 Jul;27(1):36-43. doi: 10.1016/j.nbd.2007.03.011. Epub 2007 Apr 5. Neurobiol Dis. 2007. PMID: 17512749
Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington's disease mutation in peripheral lymphocytes.
Battista N, Bari M, Tarditi A, Mariotti C, Bachoud-Lévi AC, Zuccato C, Finazzi-Agrò A, Genitrini S, Peschanski M, Di Donato S, Cattaneo E, Maccarrone M. Battista N, et al. Among authors: peschanski m. Neurobiol Dis. 2007 Jul;27(1):108-16. doi: 10.1016/j.nbd.2007.04.012. Epub 2007 May 6. Neurobiol Dis. 2007. PMID: 17553686
Prospectives for cell and gene therapy in Huntington's disease.
Bachoud-Lévi AC, Hantraye P, Peschanski M. Bachoud-Lévi AC, et al. Among authors: peschanski m. Prog Brain Res. 1998;117:511-24. doi: 10.1016/s0079-6123(08)64036-4. Prog Brain Res. 1998. PMID: 9932429 Review. No abstract available.
Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF.
Bachoud-Lévi AC, Déglon N, Nguyen JP, Bloch J, Bourdet C, Winkel L, Rémy P, Goddard M, Lefaucheur JP, Brugières P, Baudic S, Cesaro P, Peschanski M, Aebischer P. Bachoud-Lévi AC, et al. Among authors: peschanski m. Hum Gene Ther. 2000 Aug 10;11(12):1723-9. doi: 10.1089/10430340050111377. Hum Gene Ther. 2000. PMID: 10954906
Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study.
Bloch J, Bachoud-Lévi AC, Déglon N, Lefaucheur JP, Winkel L, Palfi S, Nguyen JP, Bourdet C, Gaura V, Remy P, Brugières P, Boisse MF, Baudic S, Cesaro P, Hantraye P, Aebischer P, Peschanski M. Bloch J, et al. Among authors: peschanski m. Hum Gene Ther. 2004 Oct;15(10):968-75. doi: 10.1089/hum.2004.15.968. Hum Gene Ther. 2004. PMID: 15585112 Clinical Trial.
Motor and cognitive improvements in patients with Huntington's disease after neural transplantation.
Bachoud-Lévi AC, Rémy P, Nguyen JP, Brugières P, Lefaucheur JP, Bourdet C, Baudic S, Gaura V, Maison P, Haddad B, Boissé MF, Grandmougin T, Jény R, Bartolomeo P, Dalla Barba G, Degos JD, Lisovoski F, Ergis AM, Pailhous E, Cesaro P, Hantraye P, Peschanski M. Bachoud-Lévi AC, et al. Among authors: peschanski m. Lancet. 2000 Dec 9;356(9246):1975-9. doi: 10.1016/s0140-6736(00)03310-9. Lancet. 2000. PMID: 11130527 Clinical Trial.
Progress and prospects: gene therapy clinical trials (part 2).
Aiuti A, Bachoud-Lévi AC, Blesch A, Brenner MK, Cattaneo F, Chiocca EA, Gao G, High KA, Leen AM, Lemoine NR, McNeish IA, Meneguzzi G, Peschanski M, Roncarolo MG, Strayer DS, Tuszynski MH, Waxman DJ, Wilson JM. Aiuti A, et al. Among authors: peschanski m. Gene Ther. 2007 Nov;14(22):1555-63. doi: 10.1038/sj.gt.3303033. Gene Ther. 2007. PMID: 17984995 Review.
242 results